Search NLS News

The analysis of data from the phase IIa clinical study SPAGOPIX-02 with the contrast agent pegfosimer manganese confirms that the primary endpoint of measuring the MRI enhancing effect in endometriotic lesions was met, with an overall acceptable safety profile. “The promising results and conclusions from this first clinical trial with pegfosimer manganese in endometriosis strengthen […]

Elekta has announced a pilot collaboration with Bristol Myers Squibb to develop a digital solution for patients with melanoma. “We are thrilled to collaborate with Bristol Myers Squibb to potentially advance the use of digital health interventions, such as in the treatment of melanoma,” says Anish Patankar, SVP & Head of Business Line Software at […]

Norges forskningsråd awards more than NOK 808 million to innovation projects in the industry. Several of these companies are also a part of Oslo Cancer Cluster Incubator. It is indeed a validation of the quality of the ecosystem.” “This is foremost fantastic news to hard working and risk-taking individuals in the companies, congratulations! It is […]

Nykode Therapeutics has announced an expansion of the pipeline with a potential first-in-class preclinical oncology vaccine program aimed at preventing and treating colorectal cancer. “The potential first-in-class program reaffirms Nykode’s vision of building a balanced cancer vaccine portfolio. We are excited about the transformative power of our next-generation technology with the potential to reduce the […]

How to align your pharmaceutical supply chain with the crucial GDP demands. Quality and integrity expectations are soaring in the life science industry. Adhering to Good Distribution Practice (GDP) is as a result crucial for pharmaceutical companies aiming for optimal results in projects, clinical trials, and supply chain management. John Coleman, Business Unit Director at […]

Norway’s strengths in immunology and cancer R&D have probably not gone unnoticed by anyone within the Nordic life science industry, and perhaps also beyond. Next in a line of promising Norwegian spin-outs is Oncosyne – with a quest to become a leading provider of cell-based cancer diagnostics. Cancer is the second leading cause of death […]

Jari Närhi, CEO of NADMED, describes the life science environment in Helsinki and shares his favorite spots. Describe the vibe in Helsinki for a company like yours! “Helsinki has wonderful tightly-knit startup and deep scientific communities that provide a great environment to develop novel, cutting-edge technologies and applications in biotech and medtech. The city is […]

Nanoparticles have not only found practical applications but have also ignited significant interest in the field of nanoscience and their potential applications in biology. Quantum dots have for instance the capability to label biological tissues, providing valuable insights into the various cellular structures.

Mendus has reported positive updated survival data from the Phase 2 ADVANCE II trial evaluating vididencel in acute myeloid leukemia (AML). The longer-term follow up data showed durable treatment responses with survival benefit exceeding historical results expected from the current standard of care in AML maintenance therapy, the company states. “We are obviously very pleased […]

AstraZeneca has entered into a definitive agreement to acquire Icosavax, a US-based clinical-stage biopharma company focused on developing vaccines using a protein virus-like particle (VLP) platform. The proposed acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus (RSV), strengthening AstraZeneca’s Vaccines & Immune Therapies late-stage pipeline with Icosavax’s lead investigational vaccine candidate, IVX-A12, the […]